Precision for Medicine, the owner of marketing agency Precision for Value, announced it received a $75 million investment from private equity firm TPG Growth.
Precision for Medicine stated in the same release that it plans to use the funds to expand its research and commercialization capabilities as well as expand globally.
The company declined to elaborate on those plans or the terms of the deal.
TPG Growth Partner Matthew Hobart explained the motivations behind the investment in a release: “Precision for Medicine operates at the intersection of two of the fastest-growth areas in healthcare—precision medicine and value-based care. “
This isn’t TPG’s first investment in the healthcare industry. The company has also invested in IMS Health and it acquired Par Pharmaceutical for $1.9 billion in 2012 before selling it to Endo for $8 billion earlier this year.
Precision for Value acquired a healthcare economics firm, Redwood Outcomes, in November that was folded into Precision Health Economics, which was purchased in 2013.
